ESMO: Combination Treatment Improves Survival in Muscle-Invasive Bladder Cancer

Perioperative durvalumab with or without tremelimumab plus enfortumab vedotin before cystectomy yields better event-free survival outcomes than surgery alone
bladder
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on: 
Updated on: 
Loading content, please wait...